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Cerebrospinal fluid (CSF) is in close contact with the diseased areas in 
neurological disorders and is therefore an important source of material in the 
search for molecular biomarkers. CSF is withdrawn from patients in a clinical 
setting where sample handling might not always be adequate in view of 
proteomic and metabolomic studies.  We therefore initiated a combined 
proteomics and metabolomics study of the impact of time delay between sampling 
and freezing of CSF samples.  
We left CSF for 0, 30 and 120 min at room temperature after sample 
collection and subsequent centrifugation/removal of cell pellet. We analyzed the 
CSF samples at five separate laboratories using five different analytical platforms: 
Proteome analysis with nanoLC Orbitrap-MS/MS and chipLC QTOF-MS after 
tryptic digestion; metabolome analysis with NMR and GC-MS; and amino acid 
analysis with LC-MS. 
Our results show that changes in the metabolome and proteome of human 
CSF left at room temperature after centrifugation are minor compared to the 
biological variation between the samples. The delayed storage at room 
temperature resulted in few but statistically significant changes in the proteome 
and metabolome. We detected two non-identified peptides as well as one 
metabolite; 2,3,4-trihydrobutanoic acid, that changed significantly. 
With the applied analysis strategies the proteome/metabolome profile of 
centrifuged, human CSF with all cells removed proved to be rather stable even 
when stored at room temperature for up to two hours. This gives the laboratory 
personnel at the collection site time to aliquot samples before freezing and storage 
at -80 °C. 





The conditions during the journey of a biological sample from the clinical 
collection site to the analytical research laboratory may not always be adequate for 
subsequent proteomics and metabolomics analyses, especially in cases where the 
sample collection was not originally performed with these large-scale analyses in 
mind. In order to detect reliable molecular biomarker candidates it is imperative to 
handle biological fluids according to standardized procedures and to evaluate the 
effect of pre-analytical parameters on the final result to avoid artifacts (1, 2). 
Earlier studies on urine, plasma and cerebrospinal fluid (CSF) have shown that 
sample handling can affect the stability of proteins as well as metabolites (3-11). 
Sample handling according to standardized procedures is also important when 
trying to compare results between different laboratories (12-14). In the search for 
molecular biomarkers related to disorders of the central nervous system, CSF is 
the most promising bio-fluid, because of the proximity to the affected tissue (13, 
15-20). 
This study complements our previous stability study where we showed 
that a number of proteins and metabolites changed over a time period of two 
hours at room temperature in porcine CSF samples that contained low levels of 
remaining white blood cells (21). In this study we have analyzed a set of human 
CSF samples in order to assess protein and metabolite stability at room 
temperature after a low-speed centrifugation step to remove cells. To cover a wide 
range of proteins and metabolites, the results from a number of analytical 
platforms comprising LC-MS, GC-MS and NMR have been combined. To our 




2. Material and Methods 
2.1. Sample set 
Six human CSF samples were obtained from the Department of Neurology at the 
Erasmus University Medical Center (Rotterdam, The Netherlands). The CSF 
samples were collected as part of routine clinical examinations of the patients with 
various symptoms (Table 1). All samples were withdrawn via lumbar puncture 
between the 3rd and 4th lumbar vertebrae using a Spinocan needle (0.90 × 88 mm). 
The Medical Ethical Committee of the Erasmus University Medical Center in 
Rotterdam, The Netherlands, approved the study protocol and all patients gave 
their consent. Samples were centrifuged (10 min at 956 g) immediately after 
collection (maximum time between sample collection and centrifugation was 




liquid nitrogen or left at room temperature for 30 and 120 min before snap 
freezing and storage at -80 °C. Routine CSF diagnostics including total protein and 
albumin concentration measurements as well as intrathecal cell count were 
performed and absence of hemoglobin and apolipoprotein B100 was assured to 
eliminate the possibility that samples were contaminated with blood. Samples H2 
- H6 were analyzed by all platforms. Sample H1 was analyzed by the chipLC 
QTOF-MS and the nanoLC Orbitrap-MS/MS platforms only. Protein digestion for 
proteomic analysis was performed as previously described (21). Before analysis on 
each platform the samples were exposed to two freeze-thaw cycles. Since this 
factor was kept constant for all samples it had no effect on sample quality. 
 
 
Table 1. Description of CSF samples used for the stability study. 











































































H1 49 M Migraine 0.415 0.193 0 
H2 56 M Idiopathic intracranial hypertension 0.472 0.247 0 
H3 69 F Headache 0.395 0.236 0 
H4 48 M Idiopathic intracranial hypertension 0.436 0.241 0 
H5 29 F Clinical isolated syndrome (Neuromyelitis optica) 0.387 0.226 0 
H6 38 F Epilepsy 0.381 0.184 0 
 
2.2. ChipLC QTOF MS proteomic analysis  
Half a microliter digested CSF samples (H1-H6: T0, T30, T120) were randomly 
injected in quintuplicate with 0.5 µL digested QC samples (pooled CSF spiked 
with cytochrome C; Fluka, part # 30396, end concentration: 375 fmol/uL) and 
blanks injected between every 10th sample for LC-MS analysis on an Agilent 
chipLC QTOF-MS system as previously described (21). Enrichment and separation 
was done using an LC chip (G4240-63001 SPQ110, Agilent Technologies 
[separation column: 150 mm × 75 µm Zorbax 300SB-C18, 5 µm; trap column: 160 
nL Zorbax 300SB-C18, 5 µm]). The LC separations were carried out as described 
earlier (21) using the following gradient:  80 min linear gradient from 3 to 40% B; 
10 min linear gradient from 40 to 50% B; 10 min linear gradient from 50 to 3% B. 
MS analysis was performed under the following conditions; mass range: 200-2000 
m/z in profile mode, acquisition rate: 1 spectrum/s, fragmentor voltage: 175 V, 
skimmer voltage: 65 V, OCT 1 RF Vpp: 750 V. The spray voltage was ~1800 V and 
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the drying gas (N2) was 6 L/min at a temperature of 325 ºC. Mass correction was 
done for each spectrum using internal standards (methyl stearate m/z: 299.294457 
and HP-1221 m/z: 1221.990637) evaporating from a wetted wick inside the spray 
chamber. Reproducibility was monitored on selected cytochrome C peaks in the 
QC samples; Mass difference between theoretical and the measured values was 
within +/- 4 ppm. The selected peaks showed a peak area RSD of less than +/- 20% 
and a retention time (RT) RSD of less than 2%. 
Data was processed using a pipeline developed in C++ (22) as previously 
described (21). MzData.XML data were converted to ASCII format over a mass 
range of 200 to 1600 m/z (outside this range no multiply charged ions were 
detected), a retention time range of 3 to 80 min (peptide elution range) and with an 
intensity threshold of 300 counts. A double cross validated Nearest Shrunken 
Centroid (NSC) (23) algorithm was applied to the complete peak matrix; the NSC 
comparison gives for a certain shrinkage value a cross validation error between 0 
and 1, where 1 imply that both classes are assigned to the wrong class, 0.5 is a 
random class assignation and 0 means that both classes are correctly assigned. 
NSC selected features were compared by univariate statistical analysis in terms of 
Student’s t-test with Bonferroni correction for multiple comparisons and ANOVA 
(Microsoft Excel 2007 and SPSS 16.0). The features were considered significantly 
different with a p-value below 0.05 (T0 vs. T120 and T0 vs. T30). Each 
discriminatory feature was analyzed by targeted tandem MS for identification. 
Principal component analysis (PCA) (24) was applied to the complete peak matrix 
(10 000 peaks) as well as on the NSC-selected features (MatLab, R2009a). For 
visualization box and whisker plots were created in Origin 7.0. 
 
2.3. NanoLC Orbitrap-MS/MS shotgun proteomics analysis 
Digested CSF samples (H1-H6: T0, T30, T120) were injected one time each in 
random order and analyzed by MS/MS (shotgun approach) on an Ultimate 3000 
nano LC system (Dionex, Germany) online coupled to a hybrid linear ion 
trap/Orbitrap mass spectrometer (LTQ Orbitrap XL; Thermo Fisher Scientific, 
Bremen, Germany) as previously described (21). 
Data files were analyzed and pre-processed using the Progenesis LC-MS 
software package (Nonlinear Dynamics, United Kingdom); retention times were 
aligned and the intensities of the ions were normalized. To assess inter-patient 
variability all identified peaks were analyzed by PCA. All identified peaks were 
also analyzed by NSC (23) for classification. Peptides were analyzed for 
differential abundance between the sample-groups by performing ANOVA, p-
values below 0.01 were considered significant.  
All MS/MS spectra were searched against the UniProt/SwissProt database 
(version 57.6, August 20, 2009, taxonomy: Homo sapiens 20070 sequences) using 




amino acid modifications: carbamidomethylation of cysteine (fixed) and oxidation 
of methionine (variable). The results were further on linked to the original data 
(Progenesis). 
 
2.4. GC-MS metabolomic analysis 
CSF samples (H2-H6: T0, T30, T120) were treated with an oximation reagent 
followed by silylation prior to GC-MS analysis (21, 25). Each sample was injected 
twice in random order and analyzed on an Agilent 6890 gas chromatograph 
coupled to an Agilent 5973 quadrupole mass spectrometer as described earlier 
(21).  
Peaks were characterized by retention time and m/z ratio and identified by 
comparison with a spectral data base (TNO) (21). All detected metabolites were 
analyzed by PCA. A two tailed Student’s t-test with Bonferroni correction for 
multiple comparisons as well as ANOVA and Kruskal-Wallis test (Microsoft Excel 
2007 and SPSS 16.0) was applied to all known metabolites (T0 vs. T30 and T0 vs. 
T120); metabolites with a p-value below 0.05 were considered significantly 
affected by storage time. 
 
2.5. NMR metabolomic analysis 
Samples (H2-H6: T0, T30, T120) were randomized prior to sample preparation and 
analysis. Fifty microliters of CSF were diluted in 200 µL of D2O (99.99 % D). 
Twenty-five µL of 8.8 mM TSP-d4 (3-(Trimethylsilyl)propionic acid-d4 sodium salt, 
99 % D) stock solution in D2O were added to 250 µL CSF to a final concentration of 
0.8 mM TSP as internal standard and as chemical shift reference (δ0.00). The TSP-
d4 stock solution was prepared from dry TSP-d4. The pH was adjusted (7.0 – 7.1) 
by adding phosphate buffer (9.7 µL of a 1 M stock solution) to a final 
concentration of 35 mM (26). Finally the sample (284.7 µL) was transferred to a 
SHIGEMI microcell NMR tube for measurements, (each sample was analyzed 
once). 
1D 1H NMR spectra were acquired on an 800 MHz Inova (Varian) system 
equipped with a 5 mm triple-resonance, Z-gradient HCN cold-probe.  Suppression 
of water was achieved using WATERGATE (delay: 85 s) (27). For each spectrum 
256 scans of 18 000 data points were accumulated with a spectral width of 9000 
Hz. The acquisition time for each scan was 2 s. An 8 s relaxation delay was 
employed between scans. Prior to spectral analysis, all acquired Free Induction 
Decays (FIDs) were zero-filled to 32 000 data points, multiplied with a 0.3 Hz line 
broadening function, Fourier transformed and manually phased. Calibration of 
the chemical shift scale was done on the external reference standard TSP-d4 by 
using ACD/SpecManager software (Advanced Chemistry Development Inc., 
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Toronto, Canada). Spectra were transformed to MatLab, version 7.6 (R2008b) 
(Mathworks, Natick, MA) for further analysis.  
NMR spectral data was preprocessed by baseline correction using the 
Asymmetric Least Squares method (28) and alignment with the Correlation 
Optimized Warping (COW) method (29). Each spectrum was divided (along the 
chemical shift axis) in equally sized bins (0.04 ppm) and each data point was 
averaged over each bin. The areas of the bins were summed to provide an integral 
so that the intensities of the peaks in such defined spectral regions were extracted. 
Each NMR spectrum was reduced to 210 variables, calculated by integrating 
regions of equal width (0.04 ppm) corresponding to the regions of δ0.7-9. To 
remove effects of variation in water resonance suppression, spectral regions 
between δ4.4-5.4 were removed. All spectra thus reduced were normalized to unit 
area. 
The data was further processed by vast scaling, in order to determine 
group-specific scaling factors (30, 31). To visualize possible systematic variation, 
grouping, trends and outliers, PCA was applied to the entire data set.   
 
2.6. LC-MS/MS amino acid analysis  
Fifteen CSF samples (H2-H6: T0, T30, T120) were prepared in triplicate as 
previously described (21). One microliter of each reaction mixture was injected in 
duplicate on an ACQUITY UPLCTM system (Waters Chromatography B.V., Etten-
Leur, The Netherlands) coupled to a Quattro Premier Xe tandem quadrupole mass 
spectrometer (Waters Corporation) operated under the MassLynx data acquisition 
software (version 4.1; Waters). Quantification and pre-analysis of the data was 
done using LC-QuanLynx (Waters) and Microsoft Excel 2003, respectively. The 
complete data set was examined by PCA. The data was further statistically 
analyzed by two-tailed Student’s t-test with Bonferroni correction and ANOVA 
(Microsoft Excel 2007, SPSS 16.0) (T0 vs. T30 and T0 vs. T120), amino acids with p-





Centrifuged human CSF samples were left at room temperature for 30 and 120 
min before being snap-frozen in liquid nitrogen and stored at -80 °C. Metabolome 
and proteome profiles were compared to control samples that were frozen 
immediately after centrifugation and subsequent removal of the cell pellet. 
Proteome profiles were obtained by chipLC QTOF-MS and nanoLC Orbitrap-




GC-MS, NMR and LC-MS (amino acid analysis). The analyses were performed in 
five separate laboratories. 
 
3.1. Proteomic analysis  
The Orbitrap-MS/MS shotgun analysis resulted in a list of 55421 peaks out of 
which 5780 peptides were identified. All identified peptides from the Orbitrap-
MS/MS data and the 10000 most intense QTOF-MS peaks (complete peak matrix) 
were used for unsupervised multivariate statistical analysis (PCA). No trend with 
respect to time left at room temperature was visible (Fig. 1A and 2A). PCA shows 
that biological variation is more prominent than the effect of time delay between 
sampling and freezing, since data points clustered according to the individual 
patients rather than according to time points (Fig. 1B-D and 2B-D).  
Both the ANOVA comparison of all peaks with respect to time groups as 
well as NSC analysis of the Orbitrap MS/MS data showed only random differences 
between the time groups (e.g. NSC analyses provided the lowest average cross 
validation error of 0.5). This lead to the conclusion that that there was no 
significant discrimination between the samples stored at -80 °C immediately after 
centrifugation and samples left at room temperature for 30 or 120 min prior to 
being frozen and stored.  
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Fig. 1. Multivariate statistical analysis (PCA) of the 10.000 most intense peaks 
selected from chipLC QTOF-MS proteomic data (quintuplicate sample analysis).  
No separation based on time between sampling and freezing (T0 [▼]/T30 [٭]/T120 [O]) is 
visible, while data from individual samples cluster together indicating that the inter-
individual differences are larger than those related to time. (A) All samples. (B) Samples 




Fig. 2. Multivariate statistical analysis (PCA) of 5780 identified peaks from 
nanoLC Orbitrap-MS/MS proteomic data (single sample analyses).  
No separation based on time between sampling and freezing (T0 [▼]/T30 
[٭]/T120 [O]) is visible, while data from individual samples cluster together 
indicating that the inter-individual differences are larger than those related to time. (A) 
All samples, (B) Samples H2 [٭]) and H5 (■). (C) Samples H1 (+) and 
H6 (▲). (D) Samples H3 (x) and H4 (♦) 
 
 
NSC analysis of the QTOF-MS data revealed that differences between T0 
and T120 were only random, with a double cross validation error of 0.5. 
Comparison of T0 versus T30 by NSC reached a minimal average cross validation 
error of 0.34 and resulted in 11 selected peaks. PCA on the NSC-selected peaks (T0 




of clustering according to time groups (Fig. 3A). Further analysis of these peaks by 
univariate statistical analysis resulted in two significantly discriminatory peaks 
(m/z: 656.335, z: 2, RT: 41 min. and 736.383, z: 3, RT: 59 min.) (Fig. 3B and 3C). 
Peak areas (combined from all samples) for the two peaks detected at m/z: 656.335 
and 736.383 were significantly decreased after the samples were left for 30 minutes 
at room temperature compared to the control samples (p < 0.00005 and p < 
0.0000005 respectively with Bonferroni-corrected t-test). These peaks were further 
decreased after 120 min (p < 1E-6 and p < 5E-9 respectively). However the double-
cross validated NSC algorithm provided the lowest cross-validation error in 
combination of 5 most selective variables which shows that the discriminatory 
power of these peaks is highly affected by samples left out in the inner loop 
during the double cross validation process. Two-way ANOVA of the two peaks 
showed that both the discrimination between the time left at room temperature as 
well as biological variation (p < 1E-15) and the interaction between the two 
variables were highly significant (p < 1E-10 for both peaks). Attempts to identify 
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Fig. 3. (A) Multivariate statistical analysis by PCA based on 11 NSC-selected 
peaks derived from chipLC QTOF-MS proteomics data (T0 [▼] vs. T30 [٭]). (B and 
C) Univariate statistical analysis of two peaks that decreased significantly with 
respect to delay time between CSF sampling and freezing at room temperature.  
Data are represented as box and whisker plots with significant p-values marked (p < 5E-5) 
(T0 vs. T30 and T0 vs. T120). (A) PCA of 11 NSC selected peaks for T0 vs. T30. (B) Peak 
detected at m/z: 656.335 that decreased significantly after 30 and 120 min at room 
temperature. (C) Peak at m/z 736.383 that decreased significantly after 30 and 120 min at 
room temperature. The statistical analysis was based on two-tailed Students t-tests with 
Bonferroni correction of the combined data from five repetitive analyses of six human CSF 




Fig. 4. Statistical analysis of metabolomics data derived from human CSF (H2-
H6). (A,B,C), Multivariate statistical analysis by PCA based on all detected 
metabolites. (D,) Univariate statistical analysis (Kruskal-Wallis non-parametric 
ANOVA) of combined data from duplicate analyses of five human CSF samples 
(H2-H6) by GC-MS. The analysis is visualized by box and whisker plots with 
significant p-value (T0 vs. T120) marked (p < 5E-3).  
(A) GC-MS (90 metabolites, duplicate sample analysis). (B) NMR (51 metabolites, single 
analysis) and (C) LC-MS targeting the 19 natural amino acids (sextuplicate analysis). 
Lower panels; (D) 2,3,4-trihydroxybutanoic acid was significantly increased (Kruskal-







3.2. Metabolomic analysis 
GC-MS analysis quantified 88 metabolites, of which 67 were assigned to known 
compounds based on spectral libraries. This analysis was complemented by 
targeted LC-MS of 19 natural amino acids. NMR analysis identified and quantified 
51 metabolites. Thirteen of the metabolites were detected by all three methods, 24 
were detected by GC-MS and NMR, 14 by GC-MS and LC-MS and 16 by NMR 
and LC-MS. In total 93 unique identified metabolites were quantified. PCA of the 
data from the different analytical platforms showed that clustering occurs 
primarily according to the individual patients rather than to the time points when 
all data are considered (Fig. 4A-C). Statistical analysis revealed that the 
concentration of 2,3,4-trihydrobutanoic acid (erythronic acid, threonic acid), 
detected by GC-MS (Fig. 4D) increased in all samples with increased time left at 
room temperature. In sample H2 the increase of this metabolite was extremely 
high after 120 minutes. Non-parametric ANOVA (Kruskal-Wallis) showed that the 
discrimination between T0 and T120 was clearly significant (p < 5E-3), Bonferroni 
corrected Student’s t-test as well as one-way ANOVA also resulted in highly 
significant group separation when the samples providing outlier value was left 





We have previously shown that the stability of proteins and metabolites in porcine 
CSF samples was affected when residual white blood cells were not completely 
removed (21). Here we present a detailed study, performed on different analysis 
platforms, into the stability of the proteome and metabolome of cell-free, human 
CSF when leaving samples at room temperature for up to 2 h to mimic the clinical 
situation. 
Unsupervised multivariate statistical analysis (PCA) of the data showed 
that patient-to-patient variation is most prominent overriding variation due to 
delay time as the data points cluster in groups of individual samples rather than in 
time-related groups. After variable selection based on the pre-classification of 
samples according to delay time, we found that only two peptides and one 
metabolite changed significantly over time. Our results demonstrate that the 
measured proteome and metabolome of human CSF samples, using the applied 
techniques, is quite stable when left at room temperature as long as all cells have 
been removed first.  
Another study on the stability of the proteome in CSF at room temperature 
pointed in the same direction with the detection of only two polypeptides that 
changed after storage (32). These samples were, however contaminated with blood 
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since both polypeptides were derived from hemoglobin. Another study showed 
that blood contamination decreases the stability of the CSF proteome (11) 
corroborating our earlier results (21). One explanation to the decreased level of the 
two non-identified peaks in the proteome analysis is the possible adsorption to the 
vial surface via e.g. hydrophobic or van der Waals interactions (21, 33, 34). 
Metabolomics revealed increased levels of 2,3,4-trihydroxybutanoic acid after 
storage at room temperature. This increase may be caused by oxidative 
degradation of ascorbic acid (35-37) because here the ascorbic acid levels were 
slightly decreased with increased time at room temperature.  This decrease, 
however, was too small to be a significant factor. Interestingly, 2,3,4-
trihydroxybutanoic acid decreased in CSF containing white blood cells (21), which 
might be due to further metabolism of the acid by enzymes released from white 
blood cells. The concentration of 2,3,4-trihydroxybutanoic acid was too low for 
NMR detection. 
The stability of metabolites and proteins measured with the most common 
analytical profiling methods is an important factor to take into consideration when 
handling biofluids and designing biomarker studies. A previous study from our 
team shows that the biological variation of some proteins and peptides have large 
variability (sometimes exceeding 100%), which requires high discriminating 
power for compounds considered as biomarker candidates (38). 
In conclusion, we report a study of combined analysis methods into the 
stability of CSF using five different analytical platforms. The results agree that 
there are minor or no significant changes in the metabolome and proteome of cell-
free CSF that was left for different time spans at room temperature as compared to 
control samples that were frozen immediately after centrifugation. Earlier studies 
showed that blood or white blood cell contamination reduces CSF stability 
considerably, emphasizing the importance of the initial centrifugation step. 
From our study we draw the conclusion that with the analysis techniques 
used in this study biological variation between individuals is far more 
pronounced than variation introduced by delay time at room temperature. This 
gives laboratory personnel sufficient time to aliquot CSF samples before being 
frozen and stored for use in similar studies. Aliquoting samples in small volumes 
reduce the number of freeze-thaw cycles at later time points, which we have 
shown to be beneficial (21). We can, however, only draw conclusions about the 
analytes detected with our analysis techniques, and it remains possible that other 
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